Company intelligence / Profile preview

Pedra Technology

Ownership: Private
Development stage: Other

Overview

Pedra Technology’s Xauron Perfusion System provides real-time quantitative feedback on tissue perfusion during vascular interventions. Early clinical studies have demonstrated safety and ease of use; a 50-patient study in Singapore is ongoing. The system aims to improve outcomes by enabling intra-operative assessment of microvascular blood flow to guide treatment decisions and reduce amputation rates in patients with PAD and CLI.

Therapeutic areas: DermatologyEndocrinologyCardiovascular
Modalities: Device
Industry: Physiological Monitoring

Partnerships

Strategic partnerships with two manufacturers of peripheral vascular devices

Beyond the preview

Go deeper on Pedra Technology.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Pedra Technology.

Explore the full profile